BIOCARDIA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.62 USD | -11.15% |
|
-10.98% | -53.63% |
| May. 21 | BioCardia to Implement 1-for-15 Reverse Stock Split; Shares Fall After Hours | MT |
| May. 14 | Transcript : BioCardia, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Chart calendar BioCardia, Inc.
03d51c0467d9f0d81f8a514eb62d.Wy3Dig-efkIuscGE2MDbZsp1O0WvkgN8JTuCqiDmWmo.NEv68Er1Rigagqji7fPiFv4YAyz3_DQoXEjDm22ULyYOepHZYKk8JVaCrg~63efe80ca41cd204d3039c94920edc43
Upcoming events on BioCardia, Inc.
Past events on BioCardia, Inc.
| 2024-05-20 12:00 pm | Annual General Meeting |
| 2024-05-14 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-14 04:02 pm | Q1 2024 Earnings Release |
| 2024-04-30 03:00 pm | Business Update Call |
| 2024-03-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-27 04:00 pm | Q4 2023 Earnings Release |
| 2024-03-03 | Technology and Heart Failure Therapeutics Conference |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:11 pm | Q3 2023 Earnings Release |
| 2023-10-18 12:00 pm | Annual General Meeting |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:05 pm | Q2 2023 Earnings Release |
| 2023-07-11 | Data Safety Monitoring Board Meeting |
| 2023-05-10 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-10 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-29 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-29 08:15 am | Q4 2022 Earnings Release |
| 2022-11-09 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-09 04:05 pm | Q3 2022 Earnings Release |
| 2022-10-24 | LD Micro Main Event XV |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,71 0,57 25.44% | 0,15 0,12 20.83% | 1,02 0,77 31.87% | 1,35 1,39 -2.45% | 0,48 0,70 -31.86% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -12,6 -11,5 -9.3% | -11,8 -12,9 8.38% | -11,6 -13,2 12.42% |
|
EBIT Million USD | Released Forecast Spread | -14,2 -14,5 1.75% | -15,5 -15,9 2.37% | -12,6 -13,7 7.95% | -11,9 -12,6 5.76% | -11,6 -13,2 11.79% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -15,0 1.92% | -15,0 -16,0 6.32% | -12,6 -14,1 10.35% | -11,9 -12,9 7.7% | -11,6 -13,1 11.67% |
|
Net income Million USD | Released Forecast Spread | -14,7 -15,0 1.92% | -15,0 -15,9 5.57% | -12,6 -13,6 7.5% | -11,9 -12,6 5.68% | -11,6 -13,1 11.67% |
|
EPS USD | Released Forecast Spread | -39,1 -41,2 5.09% | -22,2 -23,6 5.93% | -11,2 -11,5 2.6% | -10,0 -10,7 6.29% | -8,25 -6,90 -19.57% |
| Announcement Date | 09/04/20 | 30/03/21 | 29/03/22 | 29/03/23 | 27/03/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,06 0,19 -68.42% | 0,97 0,07 1311.59% | 0,21 0,11 87.61% | 0,11 0,15 -30.72% | 0,06 0,34 -81.18% | 0,04 0,18 -76.57% | 0,36 0,04 827.27% | 0,01 0,19 -93.16% |
|
EBITDA Million USD | Released Forecast Spread | -3,31 -3,00 -10.37% | -2,48 -3,50 29.14% | -3,03 -3,60 15.81% | -3,00 -4,00 25.08% | -3,49 -2,90 -20.28% | -3,43 -3,40 -0.91% | -2,58 -4,00 35.58% | -2,06 -3,60 42.67% |
|
EBIT Million USD | Released Forecast Spread | -3,33 -2,73 -21.82% | -2,50 -5,00 50.04% | -3,06 -4,03 24.12% | -3,02 -3,47 13.13% | -3,45 -3,53 2.07% | -2,60 -3,73 30.26% | -2,08 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,33 -2,81 -18.14% | -2,50 -4,95 49.59% | -3,06 -3,99 23.39% | -3,03 -4,00 24.3% | -3,50 -2,70 -29.67% | -3,42 -3,40 -0.71% | -2,57 -4,00 35.65% | -2,07 -3,60 42.44% |
|
Net income Million USD | Released Forecast Spread | -3,33 -2,81 -18.14% | -2,50 -4,57 45.36% | -3,06 -3,92 22.07% | -3,03 -3,73 18.92% | -3,50 -2,70 -29.67% | -3,42 -3,46 1.04% | -2,57 -4,00 35.65% | -2,07 -3,60 42.44% |
|
EPS USD | Released Forecast Spread | -2,85 -2,70 -5.56% | -2,10 -3,83 45.1% | -2,55 -3,30 22.73% | -2,40 -3,08 21.95% | -2,55 -2,63 2.86% | -2,55 -2,55 0% | -1,80 -1,65 -9.09% | -1,35 -1,50 10% |
| Announcement Date | 11/05/22 | 10/08/22 | 09/11/22 | 29/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 27/03/24 |
More events
Past sector events for BioCardia, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BCDA Stock
- Calendar BioCardia, Inc.
